`571-272-7822
`
`
`
` Paper 45
` Date: March 30, 2017
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`
`
`
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`____________
`
`Case IPR2016-01332
`Patent 8,822,438 B2
`____________
`
`
`
`Before LORA M. GREEN, RAMA G. ELLURU, and
`KRISTINA M. KALAN, Administrative Patent Judges.
`
`KALAN, Administrative Patent Judge.
`
`
`
`DECISION
`Motion for Pro Hac Vice Admission
`37 C.F.R. § 42.10(c)
`
`
`
`On March 27, 2017, Petitioner filed a Motion for Pro Hac Vice
`
`Admission of Ms. Shannon M. Bloodworth and an accompanying
`
`
`
`
`
`2
`
`Declaration. Paper 43; Ex. 1084. Petitioner represents that Patent Owner
`
`will not oppose this Motion. Paper 43, 1.
`
`After considering Petitioner’s Motion and accompanying Declaration,
`
`and with good cause having been shown, it is
`
`ORDERED that Petitioner’s Motion for Pro Hac Vice Admission of
`
`Ms. Bloodworth is granted;
`
`FURTHER ORDERED that Petitioner is to continue to have a
`
`registered practitioner as lead counsel in the instant proceeding, but
`
`Ms. Bloodworth is authorized to be designated as backup counsel; and
`
`FURTHER ORDERED that Ms. Bloodworth is to comply with the
`
`Office Patent Trial Practice Guide and the Board’s Rules of Practice for
`
`Trials, as set forth in Title 37, Part 42 of the Code of Federal Regulations,
`
`and is subject to the USPTO’s disciplinary jurisdiction under 37 C.F.R.
`
`§ 11.19(a) and the USPTO Rules of Professional Conduct as set forth in
`
`37 C.F.R. §§ 11.101 et seq.
`
`
`
`
`
`
`
`2
`
`
`
`3
`
`3
`
`
`
`FOR PETITIONER:
`
`Brandon White
`bmwhite@perkinscoie.com
`
`Crystal Canterbury
`ccanterbury@perkinscoie.com
`
`FOR PATENT OWNER:
`
`Dianne Elderkin
`delderkin@akingump.com
`
`Barbara Mullin
`bmullin@akingump.com
`
`Ruben Munoz
`rmunoz@akingump.com
`
`
`
`
`
`